Another new drug for type 2 diabetes, called Prandin (repaglinide)

March 1998

You'll soon see another new drug for type 2 diabetes, called Prandin (repaglinide).

It's the first of a new class...the meglitinides.

Prandin is given before meals to reduce postprandial hyperglycemia. It stimulates the pancreas to release more insulin.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote